Sign In
Buy KVUE
$19.24
-0.0700 (-0.363%)
At Close: Jul 31, 2026
Kimberly-Clark Buys Embattled Tylenol Maker Kenvue In $48 Billion Deal
09:15am, Monday, 03'rd Nov 2025
This is a developing story.
Kimberly-Clark to acquire Tylenol owner Kenvue in $48.7 billion deal
08:40am, Monday, 03'rd Nov 2025
CNBC's David Faber joins 'Squawk Box' with the latest news.
Kimberly-Clark to buy embattled Tylenol maker Kenvue in a deal valued at more than $48 billion
08:27am, Monday, 03'rd Nov 2025
Kenvue's stock, which had hit a record low in recent weeks, was headed for its best day ever while Kimberly-Clark's stock tumbled.
Tylenol maker Kenvue misses sales estimates amid Kimberly-Clark's $48.7-billion deal
08:24am, Monday, 03'rd Nov 2025
Kenvue missed Wall Street estimates for third-quarter sales on Monday, while it also announced its acquisition by Kimberly-Clark for about $48.7 billion.
KVUE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Kenvue Inc. is Fair to Shareholders
08:02am, Monday, 03'rd Nov 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Kenvue Inc. (NYSE: KVUE) to Kimberly-Clark Corporation for $3.50 per share in cash plus 0
Kimberly-Clark agrees to buy Kenvue in $48.7 billion deal, creating consumer staples giant
07:49am, Monday, 03'rd Nov 2025
Kimberly-Clark announced Monday it's struck an agreement to buy Kenvue in a deal valued at $48.7 billion. The combined company would bring together brands like Huggies and Kleenex with the likes of Ba
Kimberly-Clark to Buy Kenvue in Deal That Values Tylenol Maker at $48.7 Billion
06:50am, Monday, 03'rd Nov 2025
Kimberly-Clark will buy Kenvue for cash and stock.
Kimberly-Clark to Buy Tylenol Maker Kenvue
06:44am, Monday, 03'rd Nov 2025
The $48.7 billion deal, which includes debt, combines the maker of Huggies diapers with the owner of the painkiller maker.
Kimberly-Clark to acquire Kenvue in $48.7 billion deal
06:36am, Monday, 03'rd Nov 2025
Kimberly-Clark said on Monday it will acquire Tylenol maker Kenvue in a deal valued at about $48.7 billion.
Kenvue Reports Third Quarter 2025 Results
06:30am, Monday, 03'rd Nov 2025
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced financial results for the third quarter ended September 28, 2025. “Throughout the third quarter, our team remained focused on
Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader
06:30am, Monday, 03'rd Nov 2025
Combines Highly Complementary and Strategically Aligned Consumer Offerings, Including 10 Iconic Billion-Dollar Brands, That Will Provide Preferred Solutions Through Every Stage of Life Applies Kimberl
Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks?
06:15am, Monday, 03'rd Nov 2025
There were rumors that the FDA was going to warn pregnant women against using Tylenol. When the news finally hit, Tylenol maker Kenvue's stock had already fallen a great deal.
Financial Survey: Kenvue (NYSE:KVUE) vs. Krispy Kreme (NASDAQ:DNUT)
01:32am, Sunday, 02'nd Nov 2025
Kenvue (NYSE: KVUE - Get Free Report) and Krispy Kreme (NASDAQ: DNUT - Get Free Report) are both consumer staples companies, but which is the superior investment? We will compare the two companies bas
These 3 Dividend Stocks Yield More Than 5% and Have Payout Ratios Over 100%. Are Dividend Cuts Coming?
07:05am, Saturday, 01'st Nov 2025
Investors can look at a company's payout ratio to help gauge whether its dividend is sustainable. In some industries, however, companies use adjusted-profit calculations to assess the safety of their
Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
04:27pm, Thursday, 30'th Oct 2025
Risk-averse investors may prefer focusing on investment targets with broad approval from Wall Street analysts in the form of Buy ratings. However, sometimes attractive prospects may also be found in H
